Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (961-970 of 1,218) with videos related to

Pageof 122
Sort By:
Plos One|May 23, 2013
Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitroSusann Cattepoel, Alexander Schaub, Miriam Ender, et al.
Journal of Clinical Medicine|September 14, 2024
Impact of Positive Lymph Nodes after Systematic Perihilar Lymphadenectomy in Colorectal Liver MetastasesGabriel F Hess, Noa L E Aegerter, Jasmin Zeindler, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase geneY Guo, W K Jones, Y T Xuan, et al.
International Journal of Cancer|February 3, 2005
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapyUrs von Holzen, Michel Adamina, Martin Bolli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.
Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.
Cells|October 6, 2020
Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable NanogelsMaximilian Scherger, Evangelia Bolli, Ana Rita Pombo Antunes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 25, 2019
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophagesYannick De Vlaeminck, Quentin Lecocq, Philippe Giron, et al.
Redox Biology|August 21, 2021
Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activationRiham R E Abouleisa, Lindsey McNally, Abou Bakr M Salama, et al.
Plos One|May 9, 2014
c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heartKyung U Hong, Yiru Guo, Qian-Hong Li, et al.
Pageof 122

Showing results (961-970 of 1,218) with videos related to

Sort By:
Pageof 122
Plos One|May 23, 2013
Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitroSusann Cattepoel, Alexander Schaub, Miriam Ender, et al.
Journal of Clinical Medicine|September 14, 2024
Impact of Positive Lymph Nodes after Systematic Perihilar Lymphadenectomy in Colorectal Liver MetastasesGabriel F Hess, Noa L E Aegerter, Jasmin Zeindler, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase geneY Guo, W K Jones, Y T Xuan, et al.
International Journal of Cancer|February 3, 2005
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapyUrs von Holzen, Michel Adamina, Martin Bolli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.
Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.
Cells|October 6, 2020
Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable NanogelsMaximilian Scherger, Evangelia Bolli, Ana Rita Pombo Antunes, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 25, 2019
Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophagesYannick De Vlaeminck, Quentin Lecocq, Philippe Giron, et al.
Redox Biology|August 21, 2021
Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activationRiham R E Abouleisa, Lindsey McNally, Abou Bakr M Salama, et al.
Plos One|May 9, 2014
c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heartKyung U Hong, Yiru Guo, Qian-Hong Li, et al.
Pageof 122